SYRS

Syros Pharmaceuticals, Inc. Common Stock
SYRS

Overview Fund Activity
Delisted

SYRS was delisted on the 19th of March, 2025.

Back to rankings

64 hedge funds and large institutions have $266M invested in Syros Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-6
Holders Change %
-8.57%
% of All Funds
1.41%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
12
Increased
22
Reduced
22
Closed
17
Calls
$611K
Puts
–
Net Calls
+$611K
Net Calls Change
-$345K

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$13.5M
2
AIM
ARK Investment Management
Florida
+$4.87M
3
AG
Artal Group
Luxembourg
+$3M
4
PCM
Portolan Capital Management
Massachusetts
+$1.1M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$851K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$3.63M
2
AVM
Arch Venture Management
Illinois
-$1.48M
3
Renaissance Technologies
Renaissance Technologies
New York
-$892K
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$383K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$369K
Name Holding Trade Value Shares
Change 		Shares
Change %
HF
76
HRT Financial
New York
– -$82K -1,195 Closed
Voloridge Investment Management
77
Voloridge Investment Management
Florida
– -$78K -1,131 Closed
WEC
78
Winslow Evans & Crocker
Massachusetts
– -$44K -630 Closed
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
– -$30K -440 Closed
MAM
80
Meeder Asset Management
Ohio
– -$8K -123 Closed
Group One Trading
81
Group One Trading
Illinois
– -$1K -13 Closed
1 2 3
4